POST-AUTHORIZATION SAFETY OF LENALIDOMIDE plus DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EARLY SAFETY REPORT OF TURKISH PASS STUDY

Tuglular, A. T. FiratliPehlivan, M.Sari, H. I.Ayyildiz, M. O.Saydam, G.Sonmez, M.Besisik, S. Kalayoglu2024-04-242024-04-2420150390-6078https://hdl.handle.net/11468/2318720th Congress of European-Hematology-Association -- JUN 11-14, 2015 -- Vienna, AUSTRIA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]POST-AUTHORIZATION SAFETY OF LENALIDOMIDE plus DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EARLY SAFETY REPORT OF TURKISH PASS STUDYPOST-AUTHORIZATION SAFETY OF LENALIDOMIDE plus DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EARLY SAFETY REPORT OF TURKISH PASS STUDYConference Object100734734WOS:000361204904399Q1